GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
PONTE VEDRA, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th

7 Stable Stocks for 50% Returns by Early 2025

09:45am, Monday, 15'th Apr 2024
Investors who seek 50% returns in less than 12 months generally will have many choices within stable stocks. The general maxim regarding risk and return applies here: Risky, unstable stocks tend to of
Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET Company to Host Conference Call on Tuesday, May 7, 2024 at 4:30 pm ET
Treace Medical Concepts Inc (TMCI) Q4 2023 Earnings Call Transcript
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.08 per share a year ago.
Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ET Company to Host Conference Call on Tuesday, February 27, 2024 at 4:30 pm ET
PONTE VEDRA, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Julie Dewey - Chief Communications & Investor Relations Officer John Trea
PONTE VEDRA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts, Inc. sells medical device treatments for foot bunions. The global market for bunion correction systems is forecasted to reach $1.25 billion by 2030. Treace Medical's financial
Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET
PONTE VEDRA, Fla., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts continues to present with attractive economic characteristics. TMCI has penetrated 5.8% of the $5bn US bunion surgery market, with management revising FY'23 revenue guidance to
PONTE VEDRA, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment o
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Vivian Cervantes - IR, Gilmartin Group John Treace - CEO Mark Hair - CFO Confe
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE